| QICNX | VIHAX | QICNX / VIHAX | |
| Total Expense Ratio | 0.87 | 0.17 | 512% |
| Annual Report Gross Expense Ratio | 0.91 | 0.17 | 535% |
| Fund Existence | 13 years | 10 years | - |
| Gain YTD | 32.037 | 33.874 | 95% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 714M | 14.6B | 5% |
| Annual Yield % from dividends | 2.21 | 3.82 | 58% |
| Returns for 1 year | 31.42 | 33.47 | 94% |
| Returns for 3 years | 60.56 | 55.24 | 110% |
| Returns for 5 years | 59.63 | 57.97 | 103% |
| Returns for 10 years | 99.70 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DUKZ | 25.37 | 0.02 | +0.08% |
| Ocean Park Diversified Income ETF | |||
| DGCB | 54.35 | 0.04 | +0.07% |
| Dimensional Global Credit ETF | |||
| DFAC | 40.13 | N/A | N/A |
| Dimensional US Core Equity 2 ETF | |||
| PGHY | 19.93 | -0.02 | -0.10% |
| Invesco Glb ex-US High Yld Corp Bd ETF | |||
| BBC | 39.56 | -0.76 | -1.88% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||